Nature Photography for Mental Well-Being and Nature Connectedness in Young Adults

September 4, 2026 updated by: Beijing Normal University

Nature Photography for Mental Well-Being and Nature Connectedness in Young Adults: A Randomized Controlled Trial

This study tests whether a nature photography intervention can improve mental well-being and nature connectedness in young adults with mild emotional distress, and examines self-compassion as a key mechanism in this process. Participants are randomized to a nature photography group, a human-made object photography group , or a group receiving a stress management handbook. Eight photography tasks are delivered through a mobile platform. Outcomes are assessed at baseline, mid-intervention, post-intervention, and follow-up.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This is a three-arm randomized controlled trial examining whether nature-based photography improves mental well-being and nature connectedness among young adults with mild emotional distress. Participants are randomized to a nature photography intervention, an active control completing human-made object photography, or a control group receiving a stress management handbook. The intervention runs for 16 days and comprises eight structured photography sessions. The primary outcomes are depression (PHQ-9) and anxiety (GAD-7) symptoms at post-intervention. Secondary outcomes include nature connectedness, self-compassion, positive and negative affect, meaning in life, and life satisfaction, assessed at baseline, mid-intervention, post-intervention, and one-month follow-up. Changes in self-compassion, mindfulness, and nature connectedness are examined as hypothesized mechanisms of the intervention effect.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
300

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • PHQ-9 score ≥ 5 or GAD-7 score ≥ 5 (presence of mild or greater emotional distress).

Exclusion Criteria:

  • PHQ-9 score ≥20 or GAD-7 score ≥15 (severe depressive or anxiety symptoms).
  • Currently receiving psychological counseling or psychiatric treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Nature-Based Photography Intervention
Nature-Based Photography
Behavioral: Nature-Based Mindful Photography
Photography Participants complete an 8-session, 16-day nature-based photography intervention delivered through a WeChat mini-program (one session every two days). Each session includes a guided photography theme focused on natural elements, mindfulness and self-compassion prompts, and expressive writing, followed by optional peer support (viewing, liking, and commenting on group members' photographs) and personalized AI-assisted supportive feedback at the end of the session. The intervention is designed to improve mental well-being and strengthen nature connectedness through structured engagement with natural environments.
Experimental: Human-Made Object Photography Intervention
Human-Made Object Photography
Behavioral: Human-Made Object Photography
Participants complete an 8-session, 16-day photography intervention delivered through a WeChat mini-program, matched to the intervention group on schedule and task structure, but photographing everyday human-made objects (e.g., study tools, architectural details, furniture). Each session includes expressive writing; no nature-focused prompts, peer interaction, or AI-assisted feedback are provided. This condition controls for photography behavior, app engagement, and task contact without the nature exposure or self-compassion components.
Active Comparator: Brief Psychoeducational Stress Management Intervention
Brief Psychoeducational Stress Management
Behavioral: Self-Guided Digital Stress Management Handbook
Participants receive a self-guided digital stress management handbook over the 16-day intervention period, covering five structured modules: recognition of physical and emotional stress signals; structured energy and time management (goal decomposition, pomodoro technique, priority matrix); establishing healthy lifestyle routines (sleep hygiene, regular exercise, balanced diet); building interpersonal support networks; and accessing professional help and campus mental health resources. Participants read the handbook at their own pace without photography tasks or interactive components. This condition serves as an active comparator controlling for contact time and expectancy while excluding nature exposure and mindfulness-based self-compassion components.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Depressive Symptoms
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Depressive Symptoms Change in depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9).The PHQ-9 consists of 9 items, with each item rated from 0 (not at all) to 3 (nearly every day). Higher scores indicate greater severity of depressive symptoms and represent a worse outcome.
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Anxiety Symptoms
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Change in anxiety symptoms measured by the Generalized Anxiety Disorder-7 (GAD-7).The GAD-7 consists of 7 items, with each item rated from 0 (not at all) to 3 (nearly every day).Higher scores indicate greater severity of anxiety symptoms and represent a worse outcome.
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Nature Connectedness
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Change in connection with the natural environment measured by the Nature Connectedness Scale. Higher scores indicate greater nature connectedness and represent a better outcome.
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Self-Compassion
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Change in self-compassion measured by the Self-Compassion Scale (SCS). The scale rated on a 5-point Likert scale ranging from 1 (almost never) to 5 (almost always). Higher scores indicate greater self-compassion and represent a better outcome.
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Positive and Negative Affect
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3)
Change in emotional states measured by the Positive and Negative Affect Schedule (PANAS).The PANAS rated on a 5-point Likert scale ranging from 1 (very slightly or not at all) to 5 (extremely). Higher Positive Affect scores indicate greater positive affect and represent a better outcome, whereas higher Negative Affect scores indicate greater negative affect and represent a worse outcome.
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3)
Meaning in Life
Time Frame: Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).
Change in perceived meaning and purpose in life measured by the Meaning in Life Questionnaire (MLQ). The MLQ rated on a 7-point Likert scale ranging from 1 (absolutely untrue) to 7 (absolutely true).
Baseline (T0), Post-intervention (T2, Day 16), and 1-month Follow-up (T3).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Beijing Normal University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: xue weng, Study Principal Investigator, Beijing Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 30, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 31, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 31, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 3, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 9, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Nature Photography

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings